|By PR Newswire||
|August 7, 2014 07:25 AM EDT||
CHERTSEY, England, August 7, 2014 /PRNewswire/ --
Astellas Pharma EMEA, the regional headquarters of Astellas Pharma Inc. for Europe, the Middle East and Africa, has appointed Simon Dew to the position of Chief Strategy Officer from his previous role as Vice President: Business and Commercial Development. Simon succeeds Naoki Okamura, who after over two years in the post has moved to the Company's global headquarters in Tokyo as Corporate Vice President, Licensing & Alliances. Simon's senior team will be joined by Jun Kono, who has been appointed Vice President: Corporate Strategy and Communications.
Astellas is the second largest pharmaceutical company in Japan and among the top 20 globally. It is growing strongly in the EMEA region, with an 8.1% rise in sales to €1,967 million in FY2013. The Company's rigorous prioritisation of research and development (R&D) to produce innovative medicines that provide new standards of care for patients and their doctors, has seen a range of therapies recently launched in the region, including new classes of treatment for advanced prostate cancer, overactive bladder and the hospital-acquired infection, Clostridium difficile.
Ken Jones, President and CEO Astellas Pharma EMEA, commented: "These are important appointments to our strong senior leadership team as we review our strategic direction to support the Company's continued success. Simon has made a significant contribution to Astellas since joining eight years ago - helping ensure the Company is on track to reach goals set in our business blueprint, VISION 2015, in terms of our therapeutic focus, pipeline and sales. He has supported the region's excellent financial performance, which has seen three consecutive years of growth despite a challenging industry environment and continued austerity. Jun brings a wealth of experience in corporate strategy and planning, and we are delighted that he is returning to the EMEA from our Head Office in Japan."
As Chief Strategy Officer, Simon will play a major role in the EMEA region by helping steer Astellas as it continues to evolve its portfolio of therapies in priority disease areas. In particular, Astellas aims to further enhance its leadership in Urology and Transplantation, whilst developing a new cancer drugs portfolio to meet the Company's objective of achieving global category leadership in Oncology. Nearly a fifth of global sales are invested in R&D in a multi-track approach that combines in-house drug discovery, in-licensing and collaborations with a wide range of research organisations.
In his new role Simon will oversee Business Development, Alliance Management, Commercial Development, and Corporate Strategy and Communications, leading a team of around 18 specialists across these functions. With 25 years in the industry and a wealth of experience in commercial development strategies and managing alliances/acquisitions, Simon's expertise will help Astellas maintain the innovative and productive pipeline that has become its hallmark.
Jun takes on leadership of Astellas Pharma EMEA's Corporate Strategy and Communications and will be responsible for guiding the strategic direction of the Company's mid-term plan, product portfolio and commercial operations. He will also lead development of Astellas' growing profile in the EMEA region, building the Company's corporate brand through communications targeting a wide range of internal and external stakeholders. In addition, Jun will be responsible for planning and directing Astellas Pharma EMEA's programme of corporate social responsibility (CSR) initiatives.
Notes to Editors
About Simon Dew
Simon joined Astellas in 2006, shortly after the Company was established, as Senior Manager Business Development. As well as establishing specialist EMEA commercial and business development capabilities and building the Company's profile as a partner of choice, Simon has provided strategic direction and managed external alliances to ensure the pipeline supports priority franchise areas and delivers new products that meet approval and reimbursement requirements across European markets. Under his leadership, his team played a significant role in the commercialisation of XTANDI™ (enzalutamide), a new treatment for advanced prostate cancer, developed in partnership with Medivation, which is a pivotal part of Astellas' growing oncology portfolio.
Simon originally qualified as a pharmacist and has broad experience in the pharmaceutical and biotech industry through previous roles at Quintiles Transnational, PAREXEL International, Phytopharm, SmithKline Beecham and Bristol Myers Squibb.
About Jun Kono
Jun was appointed to a strategic planning role at Yamanouchi in 2003, where he was a key member of the merger-integration project to form Astellas in 2005. Since then he has expanded his expertise in corporate strategy and business development, through his engagement in projects for corporate vision, company acquisition and in/out licensing of various assets. His most recent role as Vice President: Head of Executive Office at the Company's Tokyo headquarters focused on corporate senior global management, including work with senior leaders to enhance operational performance thorough cross-functional collaboration. Jun has worked both in Japan and the UK, and between 2006 and 2010 was Associate Director, Strategic Planning for the EMEA region.
Jun received a Master of Business Administration (Hons.) from the University of Chicago Booth School of Business.
About Astellas Pharma EMEA
Astellas Pharma EMEA operates in 40 countries across Europe, the Middle East and Africa, and is the regional business of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. The organisation's focus is to deliver outstanding R&D and marketing to continue growing in the world pharmaceutical market. Astellas presence in Europe also includes an R&D site and three manufacturing plants. The company employs approximately 4,350 staff across these regions. For more information about Astellas Pharma EMEA, please visit http://www.astellas.eu.
Containers are revolutionizing the way we deploy and maintain our infrastructures, but monitoring and troubleshooting in a containerized environment can still be painful and impractical. Understanding even basic resource usage is difficult - let alone tracking network connections or malicious activity. In his session at DevOps Summit, Gianluca Borello, Sr. Software Engineer at Sysdig, will cover the current state of the art for container monitoring and visibility, including pros / cons and li...
Oct. 10, 2015 12:00 AM EDT Reads: 244
Too often with compelling new technologies market participants become overly enamored with that attractiveness of the technology and neglect underlying business drivers. This tendency, what some call the “newest shiny object syndrome,” is understandable given that virtually all of us are heavily engaged in technology. But it is also mistaken. Without concrete business cases driving its deployment, IoT, like many other technologies before it, will fade into obscurity.
Oct. 10, 2015 12:00 AM EDT Reads: 171
Containers have changed the mind of IT in DevOps. They enable developers to work with dev, test, stage and production environments identically. Containers provide the right abstraction for microservices and many cloud platforms have integrated them into deployment pipelines. DevOps and Containers together help companies to achieve their business goals faster and more effectively.
Oct. 10, 2015 12:00 AM EDT Reads: 211
As a CIO, are your direct reports IT managers or are they IT leaders? The hard truth is that many IT managers have risen through the ranks based on their technical skills, not their leadership ability. Many are unable to effectively engage and inspire, creating forward momentum in the direction of desired change. Renowned for its approach to leadership and emphasis on their people, organizations increasingly look to our military for insight into these challenges.
Oct. 9, 2015 11:15 PM EDT Reads: 198
SYS-CON Events announced today that Dyn, the worldwide leader in Internet Performance, will exhibit at SYS-CON's 17th International Cloud Expo®, which will take place on November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Dyn is a cloud-based Internet Performance company. Dyn helps companies monitor, control, and optimize online infrastructure for an exceptional end-user experience. Through a world-class network and unrivaled, objective intelligence into Internet condit...
Oct. 9, 2015 11:00 PM EDT Reads: 639
Today air travel is a minefield of delays, hassles and customer disappointment. Airlines struggle to revitalize the experience. GE and M2Mi will demonstrate practical examples of how IoT solutions are helping airlines bring back personalization, reduce trip time and improve reliability. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Dr. Sarah Cooper, M2Mi's VP Business Development and Engineering, will explore the IoT cloud-based platform technologies driv...
Oct. 9, 2015 10:15 PM EDT Reads: 137
SYS-CON Events announced today that Spirent Communications, the leader in testing navigation and positioning systems, will exhibit at SYS-CON's @DevOpsSummit Silicon Valley, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Spirent Communications enables innovations in communications technologies that help connect people. Whether it is service provider, data centers, enterprise IT networks, mobile communications, connected vehicles or the Inte...
Oct. 9, 2015 10:00 PM EDT Reads: 198
The IoT market is on track to hit $7.1 trillion in 2020. The reality is that only a handful of companies are ready for this massive demand. There are a lot of barriers, paint points, traps, and hidden roadblocks. How can we deal with these issues and challenges? The paradigm has changed. Old-style ad-hoc trial-and-error ways will certainly lead you to the dead end. What is mandatory is an overarching and adaptive approach to effectively handle the rapid changes and exponential growth.
Oct. 9, 2015 10:00 PM EDT Reads: 244
Who are you? How do you introduce yourself? Do you use a name, or do you greet a friend by the last four digits of his social security number? Assuming you don’t, why are we content to associate our identity with 10 random digits assigned by our phone company? Identity is an issue that affects everyone, but as individuals we don’t spend a lot of time thinking about it. In his session at @ThingsExpo, Ben Klang, Founder & President of Mojo Lingo, will discuss the impact of technology on identity....
Oct. 9, 2015 10:00 PM EDT Reads: 453
There are many considerations when moving applications from on-premise to cloud. It is critical to understand the benefits and also challenges of this migration. A successful migration will result in lower Total Cost of Ownership, yet offer the same or higher level of robustness. Migration to cloud shifts computing resources from your data center, which can yield significant advantages provided that the cloud vendor an offer enterprise-grade quality for your application.
Oct. 9, 2015 09:30 PM EDT Reads: 313
DevOps is gaining traction in the federal government – and for good reasons. Heightened user expectations are pushing IT organizations to accelerate application development and support more innovation. At the same time, budgetary constraints require that agencies find ways to decrease the cost of developing, maintaining, and running applications. IT now faces a daunting task: do more and react faster than ever before – all with fewer resources.
Oct. 9, 2015 09:00 PM EDT Reads: 416
The buzz continues for cloud, data analytics and the Internet of Things (IoT) and their collective impact across all industries. But a new conversation is emerging - how do companies use industry disruption and technology enablers to lead in markets undergoing change, uncertainty and ambiguity? Organizations of all sizes need to evolve and transform, often under massive pressure, as industry lines blur and merge and traditional business models are assaulted and turned upside down. In this new da...
Oct. 9, 2015 08:00 PM EDT Reads: 316
The web app is agile. The REST API is agile. The testing and planning are agile. But alas, data infrastructures certainly are not. Once an application matures, changing the shape or indexing scheme of data often forces at best a top down planning exercise and at worst includes schema changes that force downtime. The time has come for a new approach that fundamentally advances the agility of distributed data infrastructures. Come learn about a new solution to the problems faced by software organ...
Oct. 9, 2015 08:00 PM EDT Reads: 935
Achim Weiss is Chief Executive Officer and co-founder of ProfitBricks. In 1995, he broke off his studies to co-found the web hosting company "Schlund+Partner." The company "Schlund+Partner" later became the 1&1 web hosting product line. From 1995 to 2008, he was the technical director for several important projects: the largest web hosting platform in the world, the second largest DSL platform, a video on-demand delivery network, the largest eMail backend in Europe, and a universal billing syste...
Oct. 9, 2015 06:45 PM EDT Reads: 230
Electric power utilities face relentless pressure on their financial performance, and reducing distribution grid losses is one of the last untapped opportunities to meet their business goals. Combining IoT-enabled sensors and cloud-based data analytics, utilities now are able to find, quantify and reduce losses faster – and with a smaller IT footprint. Solutions exist using Internet-enabled sensors deployed temporarily at strategic locations within the distribution grid to measure actual line lo...
Oct. 9, 2015 06:30 PM EDT Reads: 140